Identification of Key Biomarkers and Immune Infiltration in Liver Tissue after Bariatric Surgery.

Disease markers(2022)

引用 3|浏览6
暂无评分
摘要
Our knowledge of the mechanisms by which bariatric surgery benefits the liver and the discovery of LCP1 is expected to serve as potential biomarkers or therapeutic targets for NAFLD and NASH.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络